Domestic equities ended lower amid global uncertainty and caution ahead of key US inflation data. Despite market weakness, analysts remain ...

Wall Street indexes opened higher on Tuesday, driven by a second consecutive day of gains for chipmakers. Easing Middle East tensions also ...

Major Wall Street indexes saw a strong rebound. This recovery was driven by gains in chip stocks. Signs of de-escalation in Middle East ten...

Police in Thrissur, Kerala, arrested a man after a drug raid. He attempted to hide ganja inside a pressure cooker filled with rice. The unu...

India's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including carboplatin ...

Uzbekistan is inviting Indian drug companies to invest more. They are offering better subsidies and technology help. This aims to make Uzbe...

European shares climbed Tuesday, led by technology stocks boosted by strong forecasts from STMicroelectronics amid AI demand. Investors awa...

Protein-rich foods are becoming more expensive in India. Global supply issues and rising demand are pushing up the cost of whey, a key ingr...

Indian markets await clarity on Strait of Hormuz shipping. Ashi Anand of IME Capital suggests a defensive market approach. Oil prices near ...

Tamil actor Vijay's party, Tamilaga Vettri Kazhagam, has taken charge as Tamil Nadu's new government. Vijay is now the Chief Minister. The ...

Iran's economy faces severe disruption from U.S. and Israeli strikes. Factories are shut, leading to mass job losses and soaring prices for...

A Gujarat NGO is pushing the government to regulate nutraceuticals like medicines. They cite concerns about product quality and unregulated...

The ongoing conflict in Iran is impacting India's healthcare sector. Pharmaceutical distributors warn of significant price increases for es...

The immediate net consumer impact could be 3-5% higher prices, or roughly similar to what consumers paid before the late-September cuts in ...

The US has slapped up to 100% tariffs on patented drugs, sparing generics and biosimilars but exposing India’s speciality pharma players. S...

Local drug manufacturers are struggling to produce essential cancer medicines like carboplatin and cisplatin due to a significant surge in ...

India's parliamentary committee criticized the drug pricing regulator for approving a 50% price increase on 11 drug formulations in October...